People · Operator

Greg Schenk

Named in public records as an officer, director or promoter · active 2008–2014 · Other Health Care, Other

2
Companies
5
Filings
$5.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Larada Sciences IncOther Health CareSeed$4.0M$9.9M2008
VisualShare, Inc.OtherPre-Seed$970K$16.4M2013
Operator network

Greg Schenk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Yuri Pikover · 9 companies · 1 sharedYuri PikoverLarry D. Rigby · 2 companies · 1 sharedLarry D. RigbyBrent Sloan · 1 companies · 1 sharedBrent SloanClaire Roberts · 1 companies · 1 sharedClaire RobertsDale Clayton · 1 companies · 1 sharedDale ClaytonDale D. Clayton · 1 companies · 1 sharedDale D. ClaytonDavid R. Rudd · 1 companies · 1 sharedDavid R. RuddDavid Rudd · 1 companies · 1 sharedDavid RuddGene D. Jones · 1 companies · 1 sharedGene D. JonesGreg D. Schenk · 1 companies · 1 sharedGreg D. SchenkJames D. Carlson · 1 companies · 1 sharedJames D. CarlsonRandall D. Block · 1 companies · 1 sharedRandall D. BlockLarry Rigby · 1 companies · 1 sharedLarry RigbyPatricia Goede · 1 companies · 1 sharedPatricia GoedeLarada Sciences Inc · $4.0M raisedLarada Sciences IncVisualShare, Inc. · $1.0M raisedVisualShare, Inc.Greg SchenkGS
Greg Schenk Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Greg Schenk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Yuri Pikover19
Larry D. Rigby12
Brent Sloan11
Claire Roberts11
Gene D. Jones11
David R. Rudd11
Randall D. Block11
James D. Carlson11
Greg D. Schenk11
Dale Clayton11
Dale D. Clayton11
Larry Rigby11
Patricia Goede11
David Rudd11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.